Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 31-40 of 47 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
1999Assessment of interlaboratory performance in the provision of perhexiline therapeutic drug monitoring services in Australia.Sallustio, B.; Morris, R.
1999Some international approaches to aminoglycoside monitoring in the extended dosing interval eraMorris, R.; Sallustio, B.; Vinks, A.; LeGatt, D.; Verjee, Z.; Desoky, E.
2004Concentration-time profile for perhexiline and hydroxyperhexiline in patients at steady stateJones, T.; Morris, R.; Horowitz, J.
2004Development of a regimen for rapid initiation of perhexiline therapy in acute coronary syndromesPhilpott, A.; Chandy, S.; Morris, R.; Horowitz, J.
2006Suspected DLIS interference in the dimension DGNA digoxin assay method and the clinical application of the revised digoxin target rangeMorris, R.; Jones, T.; Goldsworthy, S.; Wagner, T.; Ho, H.; Horowitz, J.
2006A Bayesian approach for population pharmacokinetic modelling of sirolimusDansirikul, C.; Morris, R.; Tett, S.; Duffull, S.
2005Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipientsDansirikul, C.; Duffull, S.; Morris, R.; Tett, S.
2004Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexilineDavies, B.; Coller, J.; James, H.; Gillis, D.; Somogyi, A.; Horowitz, J.; Morris, R.; Sallustio, B.
2007Effect of CYP2D6 metabolizer status on the disposition of the (+) and (-) enantiomers of perhexiline in patients with myocardial ischaemiaInglis, S.; Herbert, M.; Davies, B.; Coller, J.; James, H.; Horowitz, J.; Morris, R.; Milne, R.; Somogyi, A.; Sallustio, B.
2011Comparison of blood sirolimus, tacrolimus and everolimus concentrations measured by LC-MS/MS, HPLC-UV and immunoassay methodsSallustio, B.; Noll, B.; Morris, R.